Novel activities of safe-in-human broad-spectrum antiviral agents

Show full item record



Permalink

http://hdl.handle.net/10138/301108

Citation

Ianevski , A , Zusinaite , E , Kuivanen , S , Strand , M , Lysvand , H , Teppor , M , Kakkola , L , Paavilainen , H , Laajala , M , Kallio-Kokko , H , Valkonen , M , Kantele , A , Telling , K , Lutsar , I , Letjuka , P , Metelitsa , N , Oksenych , V , Bjørås , M , Nordbø , S A , Dumpis , U , Vitkauskiene , A , Öhrmalm , C , Bondeson , K , Bergqvist , A , Aittokallio , T , Cox , R J , Evander , M , Hukkanen , V , Marjomaki , V , Julkunen , I , Vapalahti , O , Tenson , T , Merits , A & Kainov , D 2018 , ' Novel activities of safe-in-human broad-spectrum antiviral agents ' , Antiviral Research , vol. 154 , pp. 174-182 . https://doi.org/10.1016/j.antiviral.2018.04.016

Title: Novel activities of safe-in-human broad-spectrum antiviral agents
Author: Ianevski, Aleksandr; Zusinaite, Eva; Kuivanen, Suvi; Strand, Mårten; Lysvand, Hilde; Teppor, Mona; Kakkola, Laura; Paavilainen, Henrik; Laajala, Mira; Kallio-Kokko, Hannimari; Valkonen, Miia; Kantele, Anu; Telling, Kaidi; Lutsar, Irja; Letjuka, Pille; Metelitsa, Natalja; Oksenych, Valentyn; Bjørås, Magnar; Nordbø, Svein Arne; Dumpis, Uga; Vitkauskiene, Astra; Öhrmalm, Christina; Bondeson, Kåre; Bergqvist, Anders; Aittokallio, Tero; Cox, Rebecca J.; Evander, Magnus; Hukkanen, Veijo; Marjomaki, Varpu; Julkunen, Ilkka; Vapalahti, Olli; Tenson, Tanel; Merits, Andres; Kainov, Denis
Contributor: University of Helsinki, Medicum
University of Helsinki, Department of Virology
University of Helsinki, Clinicum
University of Helsinki, Clinicum
University of Helsinki, Tero Aittokallio / Principal Investigator
University of Helsinki, Medicum
University of Helsinki, Norwegian University of Science and Technology
Date: 2018-06
Language: eng
Number of pages: 9
Belongs to series: Antiviral Research
ISSN: 0166-3542
URI: http://hdl.handle.net/10138/301108
Abstract: Abstract According to the WHO, there is an urgent need for better control of viral diseases. Re-positioning existing safe-in-human antiviral agents from one viral disease to another could play a pivotal role in this process. Here, we reviewed all approved, investigational and experimental antiviral agents, which are safe in man, and identified 59 compounds that target at least three viral diseases. We tested 55 of these compounds against eight different RNA and DNA viruses. We found novel activities for dalbavancin against echovirus 1, ezetimibe against human immunodeficiency virus 1 and Zika virus, as well as azacitidine, cyclosporine, minocycline, oritavancin and ritonavir against Rift valley fever virus. Thus, the spectrum of antiviral activities of existing antiviral agents could be expanded towards other viral diseases.
Subject: 3111 Biomedicine
317 Pharmacy
ZIKA VIRUS-INFECTION
HEPATITIS-C VIRUS
INFLUENZA-A VIRUS
LIVER-TRANSPLANTATION
APPROVED DRUGS
CELL-CULTURE
MOUSE MODEL
ECHOVIRUS 1
INHIBITORS
ENTRY
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
1_s2.0_S0166354218300986_main.pdf 40.06Mb PDF View/Open
1_s2.0_S0166354218300986_main.pdf 4.108Mb PDF View/Open

This item appears in the following Collection(s)

Show full item record